AnaptysBio, Inc. (ANAB) analyst actions
Rating and price-target actions on ANAB in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the ANAB overview →
1 measured ANAB analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Anaptys Initiates Litigation Against Tesaro, a GSK Subsidiary | Press release | +3.09% | +16.67% |
Keep exploring
More ANAB: earnings → · SEC filings → · ANAB overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Avid Bioservices, Inc. (CDMO) | 354 | 0.00% | 49% |
| Celcuity Inc. (CELC) | 354 | +0.13% | 52% |
| REGENERX BIOPHARMS INC (RGRX) | 343 | 0.00% | 36% |
| Allena Pharmaceuticals, Inc. (ALNA) | 342 | 0.00% | 41% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.